MGMT promoter methylation frequency was significantly associated with an increased HNSCC risk based on the fixed effects model (Summary OR was 2.83, 95%CI = 2.25–3.56) (Fig 2). Here, MGMT is linked to head and neck squamous cell carcinoma.